Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
- PMID: 17617112
- DOI: 10.1111/j.1872-034X.2007.00119.x
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
Abstract
In the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan, 18 213 individuals were newly registered as patients with primary liver cancer at 645 medical institutions over a period of 2 years (from 1 January 2002 to 31 December 2003). Of these patients, 94.2% had hepatocellular carcinoma (HCC) and 4.1% had intrahepatic cholangiocarcinoma (ICC). In addition, 24 705 follow-up patients were registered in the survey. Epidemiological and clinicopathological factors, diagnosis and treatment were investigated in the newly registered patients, and the cumulative survival rates of newly registered patients in the 12th to 17th follow-up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment. The data obtained in this follow-up survey should contribute to future research and medical practice for primary liver cancer.
Similar articles
-
Report of the 18th follow-up survey of primary liver cancer in Japan.Hepatol Res. 2010 Nov;40(11):1043-1059. doi: 10.1111/j.1872-034X.2010.00731.x. Hepatol Res. 2010. PMID: 34818831
-
Report of the 16th follow-up survey of primary liver cancer.Hepatol Res. 2005 Jul;32(3):163-72. doi: 10.1016/j.hepres.2005.04.005. Epub 2005 Jul 18. Hepatol Res. 2005. PMID: 16024288
-
Report of the 19th follow-up survey of primary liver cancer in Japan.Hepatol Res. 2016 Mar;46(5):372-90. doi: 10.1111/hepr.12697. Hepatol Res. 2016. PMID: 26970231
-
Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.World J Surg Oncol. 2016 Aug 17;14(1):218. doi: 10.1186/s12957-016-0974-6. World J Surg Oncol. 2016. PMID: 27535234 Free PMC article. Review.
-
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan.Dig Dis. 2015 Oct;33(6):765-70. doi: 10.1159/000439101. Epub 2015 Oct 21. Dig Dis. 2015. PMID: 26488173 Review.
Cited by
-
Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case.Surg Today. 2014 Jul;44(7):1359-66. doi: 10.1007/s00595-013-0653-y. Epub 2013 Jul 5. Surg Today. 2014. PMID: 23828653 Review.
-
Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Radiat Oncol. 2013 Jan 16;8:15. doi: 10.1186/1748-717X-8-15. Radiat Oncol. 2013. PMID: 23324259 Free PMC article.
-
Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma.Springerplus. 2014 Dec 10;3:721. doi: 10.1186/2193-1801-3-721. eCollection 2014. Springerplus. 2014. PMID: 26034695 Free PMC article.
-
Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.Gut Liver. 2024 Jan 15;18(1):156-164. doi: 10.5009/gnl230057. Epub 2023 Nov 28. Gut Liver. 2024. PMID: 38013475 Free PMC article.
-
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.Liver Cancer. 2016 Jul;5(3):190-7. doi: 10.1159/000367775. Epub 2016 May 10. Liver Cancer. 2016. PMID: 27493894 Free PMC article.
LinkOut - more resources
Full Text Sources